GT200800172A - Vacuna de mycoplasma hyoneumoniae - Google Patents

Vacuna de mycoplasma hyoneumoniae

Info

Publication number
GT200800172A
GT200800172A GT200800172A GT200800172A GT200800172A GT 200800172 A GT200800172 A GT 200800172A GT 200800172 A GT200800172 A GT 200800172A GT 200800172 A GT200800172 A GT 200800172A GT 200800172 A GT200800172 A GT 200800172A
Authority
GT
Guatemala
Prior art keywords
vaccine
hyoneumoniae
mycoplasma
injunction
administration
Prior art date
Application number
GT200800172A
Other languages
English (en)
Inventor
Gregory Charles Royer
Russell Howser
Catherine Charreyre
Francis William Milward
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200800172A publication Critical patent/GT200800172A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA PRESENTE INVENCIÓN PROPORCIONA UNA VACUNA DE MYCOPLASMA HYOPNEUMONIAE Y MÉTODOS PARA SU ADMINISTRACIÓN, QUE INCLUYEN UN MÉTODO PARA INDUCIR UNA RESPUESTA INMUNE SEGURA Y PROTECTORA CONTRA MYCOPLASMA HYOPNEUMONIAE, EN KIT O CONJUNTO DE VACUNACIÓN, QUE CONTIENE UN INYECTOR SIN AGUJA DE CHORRO LÍQUIDO, Y AL MENOS UN VIAL DE VACUNAS, ENSAMBLADOS OPERATIVAMENTE PARA REALIZAR LA ADMINISTRACIÓN DE LA VACUNA A UN CERDO. T2008
GT200800172A 2006-03-03 2008-09-03 Vacuna de mycoplasma hyoneumoniae GT200800172A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77898706P 2006-03-03 2006-03-03

Publications (1)

Publication Number Publication Date
GT200800172A true GT200800172A (es) 2010-05-07

Family

ID=38475356

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200800172A GT200800172A (es) 2006-03-03 2008-09-03 Vacuna de mycoplasma hyoneumoniae

Country Status (13)

Country Link
US (1) US20080014221A1 (es)
EP (1) EP1991262A4 (es)
JP (1) JP2009528361A (es)
KR (1) KR20080100384A (es)
CN (1) CN101448521A (es)
AU (1) AU2007222016A1 (es)
BR (1) BRPI0708522A2 (es)
CA (1) CA2644195A1 (es)
CR (1) CR10291A (es)
EC (1) ECSP088787A (es)
GT (1) GT200800172A (es)
MX (1) MX2008011247A (es)
WO (1) WO2007103042A2 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
AU2010251761B2 (en) * 2009-05-19 2014-10-09 Bioproperties Pty Ltd A temperature sensitive vaccine strain of Mycoplasma hyopneumoniae and uses thereof
WO2011035267A1 (en) * 2009-09-18 2011-03-24 Orthocare Innovations Llc Self aligning prosthesis with hydraulic actuators
ES2617232T3 (es) * 2010-04-23 2017-06-15 Intervet International B.V. Una vacuna que comprende células inactivadas de bacterias Haemophilus parasuis de serotipo 5
PL2569007T3 (pl) 2010-05-11 2016-04-29 Intervet Int Bv Szczepionka przeciwko Mycoplasma Hyopneumoniae, odpowiednia do podawania w obecności przeciwciał pochodzących od matki
HUE028877T2 (en) * 2010-08-27 2017-01-30 Intervet Int Bv Test of biological activity of vaccine formulation
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
CA2837375C (en) * 2011-06-01 2019-07-16 Merial Limited Needle-free administration of prrsv vaccines
CN103018442B (zh) * 2011-09-23 2014-11-19 华中农业大学 猪肺炎支原体间接elisa抗体检测试剂盒及应用
CN103182076B (zh) * 2011-12-29 2015-06-17 北京大北农科技集团股份有限公司 一种猪支原体肺炎灭活疫苗及其制备方法
EP2814508B1 (en) * 2012-02-14 2017-04-12 Merial, Inc. Rotavirus subunit vaccines and methods of making and use thereof
CN102735851B (zh) * 2012-07-13 2014-12-31 江苏省农业科学院 一种猪肺炎支原体多重组抗原elisa检测试剂盒
HUE059179T2 (hu) * 2012-09-10 2022-10-28 Galenbio Inc Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag
CN103585622B (zh) * 2013-11-25 2015-09-02 江苏省农业科学院 猪支原体肺炎疫苗株的应用
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
AU2016380864B2 (en) * 2015-12-28 2019-10-31 Boehringer Ingelheim Animal Health USA Inc. M hyo multivalent vaccine and uses thereof
CN105999259A (zh) * 2016-05-11 2016-10-12 长春海基亚生物技术股份有限公司 无针注射狂犬病疫苗系统与应用
CN105999257A (zh) * 2016-05-11 2016-10-12 长春海基亚生物技术股份有限公司 无针注射流感疫苗系统与应用
CN105854010A (zh) * 2016-05-11 2016-08-17 长春海基亚生物技术股份有限公司 无针注射手足口病疫苗系统与应用
EP3498847A4 (en) * 2016-08-12 2020-03-04 Innovac VACCINE COMPOSITION FOR PREVENTING SWINE MYCOPLASM INFECTION COMPRISING A RECOMBINANT PROTEIN
CN108101969A (zh) * 2017-11-13 2018-06-01 南京大爻网络科技有限公司 一种与猪支原体肺炎相关的抗原及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029457B2 (en) * 1999-11-23 2006-04-18 Felton International, Inc. Jet injector with hand piece
KR20040030785A (ko) * 2001-07-02 2004-04-09 화이자 프로덕츠 인크. 마이코플라즈마 하이오뉴모니애로의 1회 투여량 예방접종
RU2354399C2 (ru) * 2003-07-24 2009-05-10 Мериал Лимитед Вакцинная композиция и способ индуцирования иммунологического ответа у животного
US7691368B2 (en) * 2005-04-15 2010-04-06 Merial Limited Vaccine formulations

Also Published As

Publication number Publication date
BRPI0708522A2 (pt) 2011-05-31
JP2009528361A (ja) 2009-08-06
MX2008011247A (es) 2008-09-11
CR10291A (es) 2009-03-06
US20080014221A1 (en) 2008-01-17
EP1991262A2 (en) 2008-11-19
EP1991262A4 (en) 2009-11-04
KR20080100384A (ko) 2008-11-17
CN101448521A (zh) 2009-06-03
AU2007222016A1 (en) 2007-09-13
WO2007103042A2 (en) 2007-09-13
WO2007103042A3 (en) 2009-02-05
ECSP088787A (es) 2008-11-27
CA2644195A1 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
GT200800172A (es) Vacuna de mycoplasma hyoneumoniae
CO6331298A2 (es) Vacunas contra coccidiosis
BRPI0922301A2 (pt) combinações de inibidor de hsp90
BR112015017206A2 (pt) sistema para reparo de válvula cardíaca
AR058325A1 (es) Anticuerpos anti mn y metodos para su utilizacion
CR10307A (es) Anteojos con caracteristicas de union a una mascarilla
AR072509A1 (es) Procedimientos, aparatos y productos de programas informaticos para proporcionar informacion
BRPI0701080A2 (pt) conjunto de cateterizaÇço trans-sÉptica e mÉtodos
DE602006015665D1 (de) Probiotische enterokokken für eine verbesserte immunität
BRPI0510430A (pt) composições e métodos para vacinação mucosal
AR056816A1 (es) Composicion con ácido docosapentenoico
TW200738263A (en) ANG2 and VEGF inhibitor combinations
BRPI0821003B8 (pt) método para aumentar a imunorreatividade
MY160041A (en) Compositions and methods for treating parasitic infections
BR112013001838A2 (pt) formulações contendo extratos de echinacea angustifólia e zingiber officinale que são úteis na redução de inflamação e dor periférica
CL2009001195A1 (es) Adyuvante inmune que comprende un inhibidor de iap capaz de modular la actividad inmune; composicion farmaceutica y vacuna que lo comprenden; metodo para mejorar una respuesta inmune de un individuo; metodo para tratar un cancer en un individuo; metodo para tratar infeccion; metodo para tratar trastornos autoinmune.
BRPI0921359A2 (pt) Antígenos que induzem a resposta imunológica contra flavivírus e métodos de uso dos mesmos
BR112014013876A2 (pt) vacina à base de toxina de clostridium difficile
CL2011000877A1 (es) Composicion inmunogena para el tratamiento y/o profilaxis de ganado contra infecciones microbiologicas porque comprende antigeno de mycoplasma bovis; metodo de coadministracion de dos o mas antigenos a un ganado bovino.
CL2011001284A1 (es) Procedimiento para la produccion de vacunas contra patogenos bacterianos que producen una toxina ab; vacuna que comprende el toxoide a y/o b de clostridium; uso de dicha vacuna contra infecciones de patogenos que producen toxinas ab.
BRPI0518571A2 (pt) peptÍdeos de alfa timosina como adjuvantes de vacina contra cÂncer
EA201390287A1 (ru) Теобромин в комбинации с отхаркивающим или муколитическим средствами для применения в терапии
BR112012028506A2 (pt) "composições que compreenden extratos de abrótano ( artemisia abrotanum) e um composto de amina"
GT200900139A (es) Metodos para el tratamiento del abuso, adiccion y dependencia del alcohol
UY36208A (es) “bacterias modificadas para vacunas mejoradas contra la brucelosis”.